Rush Oak Park Hospital has received the American Stroke Association’s (ASA) Get With The Guidelines® Stroke Silver Plus Achievement Award.
The award recognizes the hospital’s commitment and success ensuring that stroke patients receive top quality treatment according to nationally accepted standards and recommendations.
Hospitals earn the recognition by reaching a goal of treating stroke patients with 85 percent or higher compliance to core standard levels of care as outlined by the American Stroke Association for 12 consecutive months. In addition, hospitals must demonstrate 75 percent compliance to seven out of 10 stroke quality measures during the 12-month period.
“Rush Oak Park Hospital is dedicated to helping our patients achieve the best possible outcomes, and implementing the American Stroke Association’s Get With The Guidelines program helps us accomplish that by making it easier for our teams to put proven knowledge and guidelines to work on a daily basis,” said Cynthia Fisch, RN, MBA, MPH, director of Quality Management at Rush Oak Park Hospital.
According to the American Stroke Association, stroke is the number five cause of death and a leading cause of adult disability in the U.S. On average, someone suffers a stroke every 40 seconds; someone dies of a stroke every four minutes; and 795,000 people suffer a new or recurrent stroke each year.
Rush Oak Park Hospital utilizes Rush Telestroke technology which enables the community hospital to work with stroke specialists at Rush University Medical Center. Rush will also soon launch the Rush Mobile Stroke Unit to be stationed at Rush Oak Park Hospital. The unit will provide stroke diagnosis and treatment directly to people at their homes.
“Our greatest reward is caring for our patients,” said Rebecca Zobel, RN, Stroke Liaison at the hospital. “That’s why we’re committed to turning treatment guidelines into lifelines.”
The hospital has also qualified to be recognized as a recipient of the American Stroke Association’s Target: Stroke Honor Roll Award.
To qualify for the Target: Stroke Honor Roll, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke. If given intravenously in the first three hours after the start of stroke symptoms, tPA has been shown to significantly reduce the effects of stroke and lessen the chance of permanent disability. Rush Oak Park Hospital earned the award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period.